U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 216454
Company: EUGIA PHARMA
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
EXEMESTANE EXEMESTANE 25MG TABLET;ORAL Prescription AB No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
05/20/2022 ORIG-1 Approval STANDARD

Label is not available on this site.

EXEMESTANE

TABLET;ORAL; 25MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
AROMASIN EXEMESTANE 25MG TABLET;ORAL Prescription Yes AB 020753 PFIZER
EXEMESTANE EXEMESTANE 25MG TABLET;ORAL Prescription No AB 200898 ALVOGEN
EXEMESTANE EXEMESTANE 25MG TABLET;ORAL Prescription No AB 211031 BRECKENRIDGE
EXEMESTANE EXEMESTANE 25MG TABLET;ORAL Prescription No AB 210323 CIPLA
EXEMESTANE EXEMESTANE 25MG TABLET;ORAL Prescription No AB 216454 EUGIA PHARMA
EXEMESTANE EXEMESTANE 25MG TABLET;ORAL Prescription No AB 077431 HIKMA
EXEMESTANE EXEMESTANE 25MG TABLET;ORAL Prescription No AB 213547 QILU
EXEMESTANE EXEMESTANE 25MG TABLET;ORAL Prescription No AB 203315 RISING
EXEMESTANE EXEMESTANE 25MG TABLET;ORAL Prescription No AB 209208 UPSHER SMITH LABS
EXEMESTANE EXEMESTANE 25MG TABLET;ORAL Prescription No AB 202602 ZYDUS PHARMS
Back to Top